文献速递免疫规划传染病防控与疫情报告

10价肺炎球菌结合疫苗(PCV10)降低代谢活性但不减少肺炎链球菌和流感嗜血杆菌的鼻咽部携带

10-valent pneumococcal conjugate vaccine (PCV10) decreases metabolic activity but not nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae.
PubMed 文献 · Vaccine · 2017-06-28

该横断面研究纳入80例6-23月龄急性呼吸道感染患儿,53例接种PCV10、27例未接种,采用转录组学和16S宏基因组测序检测鼻咽部病原体。结果显示两组肺炎链球菌、金黄色葡萄球菌、流感嗜血杆菌和卡他莫拉菌的携带率无差异,但未接种组肺炎链球菌代谢率更高(中位数126 vs 0,p=0.004),且未接种组肺炎链球菌和流感嗜血杆菌的mRNA计数与16S DNA reads呈正相关。作者认为PCV10对肺炎球菌代谢率有病原特异性效应,RNA/DNA比值可能比鼻咽部携带更敏感地用于疫苗随访。

要点

  • PCV10接种组与未接种组四种呼吸道病原体鼻咽部携带率无差异。
  • 未接种组肺炎链球菌代谢率高于接种组(中位数126 vs 0,p=0.004)。
  • 未接种组肺炎链球菌和流感嗜血杆菌mRNA与16S DNA reads呈正相关。

核心结论

  • PCV10接种对肺炎球菌代谢率有病原特异性效应,RNA/DNA比值可能比鼻咽部携带更敏感地用于疫苗随访。

研究设计与样本

  • 横断面研究(CHIADO-IVAS),纳入80例6-23月龄急性呼吸道感染患儿,53例接种PCV10、27例未接种,采集鼻咽抽吸物,采用nCounter数字转录组学和16S rRNA宏基因组测序检测呼吸道病原体。

主要发现

  • 通过转录组学分析或16S宏基因组学分析,两组肺炎链球菌、金黄色葡萄球菌、流感嗜血杆菌或卡他莫拉菌的鼻咽部携带率均无差异。
  • 未接种组肺炎链球菌代谢率高于PCV10接种组(中位数[25-75百分位]:126[22.75-218.41] vs 0[0-47.83],p=0.004)。
  • 未接种组肺炎链球菌(r=0.707;p<0.001)和流感嗜血杆菌(r=0.525;p=0.005)的mRNA计数与16S DNA reads呈正相关,接种组则无此相关性。
  • 金黄色葡萄球菌和卡他莫拉菌未观察到上述效应。

关键数值与推荐

  • 未接种组肺炎链球菌代谢率中位数[25-75百分位]为126[22.75-218.41],PCV10接种组为0[0-47.83],p=0.004。
  • 未接种组肺炎链球菌mRNA计数与16S DNA reads相关系数r=0.707,p<0.001。
  • 未接种组流感嗜血杆菌mRNA计数与16S DNA reads相关系数r=0.525,p=0.005。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effect of pneumococcal vaccination is widely variable when measured by nasopharyngeal carriage of vaccine and non-vaccine targets. The aim of this study was to compare the carriage rates and metabolic activity of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae and Moraxella catarrhalis among children who were or were not vaccinated with PCV10. METHODS: We included children with acute respiratory infection aged 6-23months from a cross-sectional study (CHIADO-IVAS). Nasopharyngeal aspirates were collected and respiratory pathogens were quantified by nCounter digital transcriptomics (Nanostring) and metagenomic sequencing of 16S ribosomal RNA (Illumina). The metabolic rate was calculated by the ratio between RNA transcripts and 16S DNA reads. RESULTS: Out of the 80 patients in this study, 53 were vaccinated with PCV10 and 27 were unvaccinated. There was no difference in nasopharyngeal carriage rates of S. pneumoniae, S. aureus, H. influenzae or M. catarrhalis by either transcriptomic analysis or 16S metagenomics. However, unvaccinated children presented a higher metabolic rate for S. pneumoniae compared to PCV10-vaccinated children (Median [25-75th percentiles]: 126 [22.75-218.41] vs. 0[0-47.83], p=0.004). Furthermore, unvaccinated children presented a positive correlation between mRNA counts and 16S DNA reads for S. pneumoniae (r=0.707; p<0.001) and H. influenzae (r=0.525; p=0.005), in contrast to vaccinated children. No such effect was observed for S. aureus and M. catarrhalis. CONCLUSIONS: Vaccination by PCV10 exerts a pathogen-specific effect on pneumococcal metabolic rate. Pathogen RNA/DNA ratio might represent a more sensitive readout for vaccine follow-up, as compared to nasopharyngeal carriage.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Andrade DC, Borges IC, Bouzas ML, et al. 10-valent pneumococcal conjugate vaccine (PCV10) decreases metabolic activity but not nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae. Vaccine. 2017. PMID: 28668567. doi:10.1016/j.vaccine.2017.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。